508 related articles for article (PubMed ID: 33615162)
1. Flavonoid-Based Nanomedicines in Alzheimer's Disease Therapeutics: Promises Made, a Long Way To Go.
Prasanna P; Upadhyay A
ACS Pharmacol Transl Sci; 2021 Feb; 4(1):74-95. PubMed ID: 33615162
[TBL] [Abstract][Full Text] [Related]
2. Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer's Disease: Present Status and Future Opportunities.
Ovais M; Zia N; Ahmad I; Khalil AT; Raza A; Ayaz M; Sadiq A; Ullah F; Shinwari ZK
Front Aging Neurosci; 2018; 10():284. PubMed ID: 30405389
[TBL] [Abstract][Full Text] [Related]
3. Role of Flavonoids in Management of Various Biological Targets in Alzheimer's Disease: Evidence from Preclinical to Clinical Studies.
Alharbi KS; Javed Shaikh MA; Imam SS; Alshehri S; Ghoneim MM; Almalki WH; Singh SK; Kumar D; Kumar AP; Dua K; Chellappan DK; Paudel KR; Gupta G
Curr Med Chem; 2023; 30(18):2061-2074. PubMed ID: 36415096
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: review of current nanotechnological therapeutic strategies.
Baranowska-Wójcik E; Szwajgier D
Expert Rev Neurother; 2020 Mar; 20(3):271-279. PubMed ID: 31957510
[No Abstract] [Full Text] [Related]
5. Nanomedicine: A Promising Way to Manage Alzheimer's Disease.
Khan NH; Mir M; Ngowi EE; Zafar U; Khakwani MMAK; Khattak S; Zhai YK; Jiang ES; Zheng M; Duan SF; Wei JS; Wu DD; Ji XY
Front Bioeng Biotechnol; 2021; 9():630055. PubMed ID: 33996777
[TBL] [Abstract][Full Text] [Related]
6. Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties.
Nayak V; Patra S; Rout S; Jena AB; Sharma R; Pattanaik KP; Singh J; Pandey SS; Singh RP; Majhi S; Singh KR; Kerry RG
Phytomedicine; 2024 Jan; 122():155150. PubMed ID: 37944239
[TBL] [Abstract][Full Text] [Related]
7. Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review.
Vicente-Zurdo D; Rosales-Conrado N; León-González ME
Talanta; 2024 Mar; 269():125519. PubMed ID: 38086100
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-derived Compounds in Alleviating Tau-mediated Neurodegeneration.
Durairajan SSK; Selvarasu K; Bera MR; Rajaram K; Iyaswamy A; Li M
Curr Mol Pharmacol; 2022; 15(2):361-379. PubMed ID: 34488602
[TBL] [Abstract][Full Text] [Related]
9. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
11. Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update.
Jan AT; Azam M; Rahman S; Almigeiti AMS; Choi DH; Lee EJ; Haq QMR; Choi I
Front Aging Neurosci; 2017; 9():356. PubMed ID: 29163138
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology in the diagnostic and therapy for Alzheimer's disease.
Panghal A; Flora SJS
Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130559. PubMed ID: 38191034
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine-based immunotherapy for Alzheimer's disease.
Hoque M; Samanta A; Alam SSM; Zughaibi TA; Kamal MA; Tabrez S
Neurosci Biobehav Rev; 2023 Jan; 144():104973. PubMed ID: 36435391
[TBL] [Abstract][Full Text] [Related]
14. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
Dey A; Bhattacharya R; Mukherjee A; Pandey DK
Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
[TBL] [Abstract][Full Text] [Related]
15. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
Sahoo AK; Dandapat J; Dash UC; Kanhar S
J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease.
Ma TJ; Gao J; Liu Y; Zhuang JH; Yin C; Li P; Mao L; Xu J; Xu YX; Li YP; Zhao ZX; Yin Y
Mini Rev Med Chem; 2018; 18(12):1035-1046. PubMed ID: 29243575
[TBL] [Abstract][Full Text] [Related]
17. Exploring the efficacy of natural products in alleviating Alzheimer's disease.
Deshpande P; Gogia N; Singh A
Neural Regen Res; 2019 Aug; 14(8):1321-1329. PubMed ID: 30964049
[TBL] [Abstract][Full Text] [Related]
18. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
[TBL] [Abstract][Full Text] [Related]
19. Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer's Disease.
Jain U; Johari S; Srivastava P
Mol Neurobiol; 2024 Apr; 61(4):1969-1989. PubMed ID: 37831361
[TBL] [Abstract][Full Text] [Related]
20. Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease.
Kalra J; Khan A
Eur J Pharmacol; 2015 Oct; 764():571-581. PubMed ID: 26209363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
